Uses of north american ginseng fractions for treating leukemia

Details for Australian Patent Application No. 2007353145 (hide)

Owner fx Life Sciences AG

Inventors Shan, Jacqueline; Miller, Sandra C.

Agent Davies Collison Cave

Pub. Number AU-A-2007353145

PCT Pub. Number WO2008/139241

Filing date 16 May 2007

Wipo publication date 20 November 2008

International Classifications

A61K 36/258 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61K 31/715 (2006.01) - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2008/139241 Priority application(s): WO2008/139241

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007353147-Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats

2007353129-A synergistic pharmaceutical combination for the treatment of cancer